Proprotein convertase subtilisin/kexin type 9 (PCSK9) and metabolic syndrome: insights on insulin resistance, inflammation, and atherogenic dyslipidemia.
about
Dietary Strategies Implicated in the Prevention and Treatment of Metabolic SyndromePlasma triglyceride and high density lipoprotein cholesterol are poor surrogate markers of pro-atherogenic chylomicron remnant homeostasis in subjects with the metabolic syndrome.Circulating Levels of Proprotein Convertase Subtilisin/Kexin Type 9 and Arterial Stiffness in a Large Population Sample: Data From the Brisighella Heart Study.PCSK9 targets important for lipid metabolismPPAR-α agonists are still on the rise: an update on clinical and experimental findings.Effect of soy on metabolic syndrome and cardiovascular risk factors: a randomized controlled trial.Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease.Nutraceutical approaches to metabolic syndrome.PCSK9 induces a pro-inflammatory response in macrophages.Effect of alirocumab on lipids and lipoproteins in individuals with metabolic syndrome without diabetes: Pooled data from 10 phase 3 trials.PPAR Agonists and Metabolic Syndrome: An Established Role?
P2860
Q28072178-3184E23A-1688-4755-97DB-F3EC57C76EF2Q36149080-269DEB77-A558-420A-A69B-522299D8B0E1Q36362512-CBC1C78D-5F22-4102-9A14-44951E1E99B2Q37703261-EC84B39A-AD5C-4F05-9CA0-1B27CB6C627CQ39200940-4949B8C8-8FE2-4AD2-AA3F-E4A2F0BA95A6Q39273397-B467AB19-3C46-4D60-9EC8-ECCDF3A1F717Q47930272-14A37E0F-D029-40D7-AD75-4D1E27A4FDB3Q47979569-97E299AD-3C0F-4563-99A5-69179B2A0C02Q48112725-23E7AA5D-F86A-4CEC-90BC-735469BD099CQ51746011-DBDF1B62-7503-4EF7-A7DA-96AA00491E2FQ54936265-532D1AFB-6E4E-4151-9D66-9C8A988DDC3D
P2860
Proprotein convertase subtilisin/kexin type 9 (PCSK9) and metabolic syndrome: insights on insulin resistance, inflammation, and atherogenic dyslipidemia.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Proprotein convertase subtilis ...... and atherogenic dyslipidemia.
@en
type
label
Proprotein convertase subtilis ...... and atherogenic dyslipidemia.
@en
prefLabel
Proprotein convertase subtilis ...... and atherogenic dyslipidemia.
@en
P2860
P921
P1433
P1476
Proprotein convertase subtilis ...... and atherogenic dyslipidemia.
@en
P2093
Massimiliano Ruscica
Nicola Ferri
P2860
P2888
P304
P356
10.1007/S12020-016-0939-0
P577
2016-04-01T00:00:00Z